GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,224,000 | -1.7% | 51,038 | -0.5% | 0.60% | +8.5% |
| Q4 2021 | $2,262,000 | +131.1% | 51,296 | +100.1% | 0.56% | +2.6% |
| Q3 2021 | $979,000 | -6.9% | 25,633 | -2.9% | 0.54% | -7.5% |
| Q2 2021 | $1,051,000 | -19.2% | 26,390 | -27.5% | 0.58% | -23.9% |
| Q1 2021 | $1,300,000 | +30.9% | 36,412 | +34.9% | 0.77% | +11.1% |
| Q4 2020 | $993,000 | -4.2% | 26,985 | -1.9% | 0.69% | -10.1% |
| Q3 2020 | $1,036,000 | -6.8% | 27,514 | +0.9% | 0.77% | -16.9% |
| Q2 2020 | $1,112,000 | +8.4% | 27,266 | +0.7% | 0.93% | -19.4% |
| Q1 2020 | $1,026,000 | -13.6% | 27,066 | +7.1% | 1.15% | +5.2% |
| Q4 2019 | $1,187,000 | +8.5% | 25,263 | -1.4% | 1.09% | +20.4% |
| Q3 2019 | $1,094,000 | +3.4% | 25,625 | -3.1% | 0.91% | +18.2% |
| Q2 2019 | $1,058,000 | – | 26,445 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |